Avantec Vascular Corporation

What Avantec Vascular Corporation does

Avantec Vascular Corporation is a privately held medical device company founded in December 1999 in Sunnyvale, California, focused on developing, manufacturing, and marketing devices for the treatment of vascular disease. The company operates as a wholly-owned subsidiary within the Nipro Corporation group, having been acquired by Goodman Co. Ltd in 2002 (which itself became a Nipro subsidiary in 2013), and is being rebranded to "Nipro Vascular Innovations Americas" effective April 1, 2026 as part of Nipro Corporation's consolidation of its U.S. Vascular Division subsidiaries.

The company's commercial product portfolio centers on the Captus Vascular Retrieval System, a device used to retrieve foreign objects such as guidewires, coils, balloons, catheters, and filters from the cardiovascular system. The Captus features a proprietary braided loop cone design with a shapeable PEEK shaft engineered for one-to-one torque response in tortuous anatomy, along with a cross-hair inner loop suture design providing multiple snare points. Historical products include the Duraflex Coronary Stent System and Apollo Coronary Dilatation Catheter. The R&D pipeline spans vascular retrieval systems, neurovascular/peripheral coils, peripheral atherectomy devices, specialty coronary/peripheral drug-eluting stents (DES), and venous thrombectomy devices. Manufacturing occurs in an ISO Class 8 clean room under an ISO 13485-certified quality management system.

Avantec generates revenue through direct hardware sales of medical devices to hospitals, cardiac centers, interventional radiology suites, and cardiology/vascular surgery practices globally, leveraging Nipro Corporation's distribution network of over 140 companies. The company employs 51-100 people, with leadership including CEO/President Jack Hoshino (35+ years of executive management across Goodman Group and European regional operations) and CTO John To (founder of multiple vascular and orthopedic device companies including Atheromed and Ouroboros Medical, with hundreds of patents globally).

Name

Avantec Vascular Corporation

Legal name

Avantec Vascular Corporation

Website

https://avantecvascular.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Avantec Vascular Corporation is a Sunnyvale-based medical device subsidiary of Nipro Corporation that develops, manufactures, and markets vascular disease treatment devices, including the Captus Vascular Retrieval System, serving hospitals, cardiac centers, and interventional practices globally through Nipro's distribution network.

Ownership category

akta.pro rank

Product category

Vascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHAFAJ

Thrombectomy, Embolic Protection & Stroke Intervention Devices

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

SECONDARYHLAHAFAK

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

• Vascular medical devices
• Coronary stent systems
• Peripheral vascular devices
• Interventional cardiology
• Vascular retrieval devices

Headquarters

HQ city

Sunnyvale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Avantec develops, manufactures, and markets innovative medical devices for vascular disease treatment, generating revenue through product sales of coronary stents, dilatation catheters, and vascular retrieval systems to healthcare providers globally.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Avantec Vascular Corporation develops, manufactures, and markets medical devices for the treatment of vascular disease, with a current marketed portfolio centered on the Captus Vascular Retrieval System for retrieving foreign objects from the cardiovascular system. The company also developed initial products including the Duraflex Coronary Stent System and Apollo Coronary Dilatation Catheter, and operates as a subsidiary of Nipro Corporation leveraging its global distribution network.

Product overview

Avantec Vascular develops, manufactures, and markets medical devices for the treatment of vascular disease. The company's current marketed product portfolio includes the Captus Vascular Retrieval System for retrieving foreign objects from the cardiovascular system. Historical products include the Duraflex Coronary Stent System and Apollo Coronary Dilatation Catheter. Avantec is strategically located in Silicon Valley and operates as part of the Nipro Corporation group, focusing on cardiovascular, neurovascular, and peripheral vascular medical devices. The company is developing future products including vascular retrieval systems, neurovascular/peripheral coils, peripheral atherectomy devices, specialty coronary/peripheral drug-eluting stents (DES), and venous thrombectomy devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Captus Vascular Retrieval System A vascular retrieval device intended for use in the cardiovascular system to retrieve foreign objects including guidewires, coils, balloons, catheters, and filters. Features a unique braided loop cone design with shapeable PEEK shaft for tortuous anatomical procedures. Designed for interventional cardiologists, vascular surgeons, and catheterization labs performing complex retrieval procedures.
• Duraflex Coronary Stent System Coronary stent system developed by Avantec as one of the company's initial products for the treatment of coronary artery disease. Designed for interventional cardiologists performing coronary stenting procedures.
• Apollo Coronary Dilatation Catheter Coronary dilatation catheter developed as one of Avantec's initial products for treating vascular disease through balloon angioplasty. Designed for interventional cardiologists performing percutaneous coronary interventions.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• Nipro Vascular Innovations AmericascoreStrategic or Co-development Partner · 1 April 2026Avantec is merging into Nipro Vascular Innovations Americas effective April 1, 2026 as part of Nipro Corporation's organizational consolidation of U.S. subsidiaries in the Vascular Division. This represents a strategic integration to create a unified vascular innovations organization under a single brand identity.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Silk Road Medical: Silk Road Medical develops devices for carotid artery procedures and other vascular interventions. As a focused vascular device company with a single-platform strategy, it provides a comparable business model and growth trajectory benchmark for Avantec's vascular pipeline.

Direct peers

• Penumbra: Penumbra specializes in thrombectomy and neurovascular devices, directly competing with Avantec's pipeline in venous thrombectomy and neurovascular/peripheral coils. Its focus on vascular clot retrieval and embolectomy makes it a strong direct peer in the company's highest-priority growth segments.
• Inari Medical: Inari Medical (acquired by Stryker in 2025) specializes in venous thrombectomy devices, directly addressing Avantec's venous thrombectomy pipeline. As a focused, fast-growing specialist in clot retrieval, it represents the principal benchmark for Avantec's emerging venous franchise.
• Cardiovascular Systems (CSI, acquired by Abbott): CSI was a specialist in peripheral atherectomy devices before its acquisition by Abbott. As a focused atherectomy pure-play, it represents the most direct benchmark for Avantec's peripheral atherectomy pipeline product and the typical exit pathway for niche vascular device innovators.
• AngioDynamics: AngioDynamics manufactures vascular access, thrombectomy, and peripheral vascular devices, with particular strength in oncology/venous interventions. Its mid-size vascular device portfolio closely parallels Avantec's product mix across retrieval, vascular access, and peripheral interventions.
• Teleflex: Teleflex manufactures vascular access devices, retrieval/snare devices, and specialty catheters that overlap with Avantec's Captus retrieval system and coronary catheter products. Its Arrow and Teleflex Vascular Solutions lines serve the same cardiology interventional customers.

Broad incumbents

• Medtronic: Medtronic's Coronary & Structural Heart division competes across coronary stents, atherectomy, and peripheral vascular devices—the same segments as Avantec's marketed and pipeline products. As the world's largest medical device company, Medtronic represents the dominant competitive force in cardiovascular interventions.
• Abbott Vascular: Abbott's vascular division is a direct competitor in coronary stents, dilatation catheters, and structural heart devices. As a broad incumbent with vast R&D resources, hospital relationships, and a full vascular portfolio, it is the primary benchmark competitor for Avantec's product categories.
• Edwards Lifesciences: Edwards Lifesciences is a global leader in heart valve therapies and critical care, with a peripheral vascular and structural heart portfolio that overlaps with adjacent segments of Avantec's pipeline. It represents a major incumbent benchmark in cardiovascular innovation.
• Boston Scientific: Boston Scientific's Peripheral Interventions and Interventional Cardiology businesses directly overlap with Avantec's portfolio (atherectomy, drug-eluting stents, vascular retrieval, thrombectomy). It is a key competitor across multiple Avantec pipeline segments.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/avantec-vascular

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avantec Vascular Corporation